EU prevalence of HBV/HCV coinfection


EU prevalence of HBV/HCV coinfection













1. Adapted from Konopnicki D, et al. AIDS 2005;19:593–601
2. Adapted from Rockstroh J, et al. J Infect Dis 2005;192:992–1002.
3. iBase HCV coinfection 2007. Available at: http://www.i-base.info/pdf/guides/2007/HCVmay07.pdf. Accessed February 19, 2009.





Decreased cirrhosis in HIV/HCV coinfection with PI-based therapy






Recommendations for treatment of chronic HBV co-infection in HIV-infected adults: EACS guidelines


IndicationForHIVtreatment


a. Some experts believe that any HBV-infected patient requiring HAART should receive TDF + 3TC or FTC unless they have a history of TDF intolerance
b. If feasible and appropriate from the perspective of maintaining HIV suppression

European AIDS Clinical Society (EACS) Coinfection guidelines 2008. Available at: http://www.eacs.eu/guide/3_Treatment_chronic_hepatitis_coinfection.pdf. accessed February 19, 2009.




 

Recommendations for treatment of chronic HCV co-infection in HIV-infected adults: EACS guidelines


IndicationForHCVtreatment


European AIDS Clinical Society (EACS) Coinfection guidelines 2008. Available at: http://www.eacs.eu/guide/3_Treatment_chronic_hepatitis_coinfection.pdf, accessed February 19, 2009.